Huberman, M <br/><br/>
A phase I study of an outpatient regimen of recombinant human interleukin-2 and alpha-2a-interferon in patients with solid tumors.  [electronic resource] 

 -  Cancer  Oct 1991 
 - 1708-13 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>0008-543X 
<br/><br/><label>Standard No.: </label>10.1002/1097-0142(19911015)68:8<1708::aid-cncr2820680810>3.0.co;2-v  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Drug Administration Schedule<br/>Drug Evaluation<br/>Eosinophils<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Interferon alpha-2<br/>Interferon-alpha--administration & dosage<br/>Interleukin-2--administration & dosage<br/>Leukocyte Count--drug effects<br/>Lymphatic Metastasis<br/>Lymphocytes<br/>Male<br/>Middle Aged<br/>Neoplasms--blood<br/>Recombinant Proteins--administration & dosage<br/>Remission Induction